| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Hian Leng Ngiam CEO | HKEX Exchange | G31237103 CUSIP |
| China Country | 1,426 Employees | 28 May 2026 Last Dividend | - Last Split | - IPO Date |
Essex Bio-Technology Limited is a distinguished investment holding company that has carved a niche in the bio-pharmaceutical industry with its innovative and effective products. Founded in 1990 and headquartered in Zhuhai, China, the company has made significant strides in developing, manufacturing, distributing, and selling bio-pharmaceutical products not just within the People's Republic of China and Hong Kong but across international borders as well. It operates through two key segments: Ophthalmic Products and Surgical Products, focusing on the research and development of basic fibroblast growth factor (bFGF) products. These products are crucial in treating cellular proliferation, differentiation, and migration, addressing a range of medical conditions. Essex Bio-Technology's commitment to quality and therapeutic efficacy is reflected in its roster of products that span various therapeutic categories and the strategic licensing agreements with Mitotech S.A. and Mitotech LLC to expand its product portfolio further.
These include Beifushu eye drops, Beifushu eye gel, and Beifushu unit-dose eye drops, which are specifically designed for ophthalmic use. Each product in this series is formulated to assist in the treatment and care of the eyes, providing relief and protection against various eye conditions.
These are antibacterial eye drops used to treat bacterial infections of the eye. Tobramycin eye drops are effective against a wide range of bacteria, while Levofloxacin eye drops are used for the treatment of bacterial conjunctivitis.
Formulated for those suffering from dry eyes, these drops provide lubrication, thereby offering relief from the discomfort associated with dry eye syndrome.
These capsules are designed as a dietary supplement to help support and improve overall health.
Targeting burn and scald wounds, acute wounds, surgical incisions, chronic wounds, and for use in skin grafting among other applications, these products facilitate healing, demonstrating Essex Bio-Technology’s expertise in advanced wound care.
This product is instrumental in the treatment of various types of wounds, offering an effective solution for wound management and care.
This innovative dental product offers a minimally invasive method for the removal of dental caries, preserving healthy tooth structure while eliminating decay.
Designed for oral health, these granules help in maintaining oral hygiene, preventing dental issues while keeping the mouth fresh and clean.
Essex Bio-Technology is also involved in the development and distribution of biologic drugs, showcasing its commitment to addressing a wide array of medical conditions through advanced biopharmaceutical solutions.